Recommendations: Therapy for Type 2 Diabetes (2)

Recommended pharmacological therapy for hyperglycemia in type 2 diabetes1 is summarized on three slides Slide 2 of 3 If noninsulin monotherapy at maximal tolerated dose does not achieve or maintain the A1C target over 3–6 months, add a second oral agent, a GLP-1 receptor agonist, or insulin (A)51Reference American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care 2013;36(suppl 1):S22.